Our Innovation
Flagship Innovation – BacNo Gel
Introducing BacNo Gel
BacNo Gel is a patented silk fibroin-based hydrogel embedded with doxycycline, designed for post-extraction wound management.
Localized Action
Delivers antibiotics directly to the wound site, eliminating unnecessary systemic intake.
Improved Comfort
Prevents side effects like gastric irritation, nausea, and diarrhea common with oral antibiotics.
Fights AMR
Reduces over-prescription of antibiotics, addressing the global antimicrobial resistance crisis.
Dual Functionality
Provides antimicrobial protection while creating an osteogenic microenvironment for bone regeneration.
Affordable & Scalable
Designed to be accessible for patients and viable for widespread clinical adoption.
Our Innovation Edge
- Drug-Induced Hydrogelation – A breakthrough process where doxycycline itself triggers hydrogel formation with silk fibroin.
- Biocompatibility & Safety – Proven safe and effective in preclinical studies; validated under ISO 10993 protocols.
- Regenerative Potential – Supports natural bone and tissue healing beyond infection control.
- Sustainable & Affordable – Uses silk, an abundant biopolymer, making the solution cost-effective and eco-friendly.
Intellectual Property & Global Reach
Innovation Protected & Recognized
- Granted Indian Patent (2024):Method for Sustained Drug Delivery for Wound Healing Using Silk Hydrogel and Product Thereof
- PCT applications filed in USA, UK & China
- Pipeline innovations in wound care & regenerative medicine.
